fda d.i.s.c.o.: burst edition: fda approvals of opdualag (nivolumab and relatlimab-rmbw) for unre...
Published 5 months ago • 70 plays • Length 7:01Download video MP4
Download video MP3
Similar videos
-
5:00
fda d.i.s.c.o.: nivolumab for adjuvant treatment of patients with melanoma
-
6:31
fda d.i.s.c.o.: fda approval of cemiplimab-rwlc for cutaneous squamous cell carcinoma
-
1:55
fda approves opdivo® (nivolumab) in the united states
-
1:49
opdualag (nivolumab and relatlimab-rmbw)- metastatic melanoma
-
6:19
should you treat melanoma with nivolumab and relatlimab (opdualag)?
-
0:43
dr. eng on the fda approval of nivolumab plus ipilimumab in crc
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
5:35
immune checkpoint blockade: ipilimumab and the ctla-4 receptor
-
1:00:03
first fda approval for metastatic uveal melanoma: what it means for the om community
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
1:34
fda approves frontline nivolumab for advanced melanoma
-
0:46
fda approval of second-dosing schedule of nivolumab
-
0:59
dr. weber on the fda approval for fixed-dose of nivolumab
-
0:37
dr. petrylak on fda approval of nivolumab in bladder cancer
-
7:35
fda approval for abemaciclib
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
1:49
dr. luke on the fda approval of adjuvant nivolumab in melanoma
-
1:34
fda approval of frontline nivolumab/ipilimumab combo in rcc
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer